366 related articles for article (PubMed ID: 25926642)
41. Polyamine Analog Diethylnorspermidine Restricts Coxsackievirus B3 and Is Overcome by 2A Protease Mutation In Vitro.
Hulsebosch BM; Mounce BC
Viruses; 2021 Feb; 13(2):. PubMed ID: 33669273
[TBL] [Abstract][Full Text] [Related]
42. Soluble coxsackievirus B3 3C protease inhibitor prevents cardiomyopathy in an experimental chronic myocarditis murine model.
Lim BK; Yun SH; Ju ES; Kim BK; Lee YJ; Yoo DK; Kim YC; Jeon ES
Virus Res; 2015 Mar; 199():1-8. PubMed ID: 25485472
[TBL] [Abstract][Full Text] [Related]
43. Dystrophin disruption in enterovirus-induced myocarditis and dilated cardiomyopathy: from bench to bedside.
Badorff C; Knowlton KU
Med Microbiol Immunol; 2004 May; 193(2-3):121-6. PubMed ID: 12920582
[TBL] [Abstract][Full Text] [Related]
44. MDA-5 is cleaved in poliovirus-infected cells.
Barral PM; Morrison JM; Drahos J; Gupta P; Sarkar D; Fisher PB; Racaniello VR
J Virol; 2007 Apr; 81(8):3677-84. PubMed ID: 17267501
[TBL] [Abstract][Full Text] [Related]
45. The RNA template channel of the RNA-dependent RNA polymerase as a target for development of antiviral therapy of multiple genera within a virus family.
van der Linden L; Vives-Adrián L; Selisko B; Ferrer-Orta C; Liu X; Lanke K; Ulferts R; De Palma AM; Tanchis F; Goris N; Lefebvre D; De Clercq K; Leyssen P; Lacroix C; Pürstinger G; Coutard B; Canard B; Boehr DD; Arnold JJ; Cameron CE; Verdaguer N; Neyts J; van Kuppeveld FJ
PLoS Pathog; 2015 Mar; 11(3):e1004733. PubMed ID: 25799064
[TBL] [Abstract][Full Text] [Related]
46. Strand-specific RNA synthesis determinants in the RNA-dependent RNA polymerase of poliovirus.
Cornell CT; Perera R; Brunner JE; Semler BL
J Virol; 2004 May; 78(9):4397-407. PubMed ID: 15078921
[TBL] [Abstract][Full Text] [Related]
47. Antiviral activity of coxsackievirus B3 3C protease inhibitor in experimental murine myocarditis.
Yun SH; Lee WG; Kim YC; Ju ES; Lim BK; Choi JO; Kim DK; Jeon ES
J Infect Dis; 2012 Feb; 205(3):491-7. PubMed ID: 22207647
[TBL] [Abstract][Full Text] [Related]
48. Enterovirus 71 3C protease cleaves a novel target CstF-64 and inhibits cellular polyadenylation.
Weng KF; Li ML; Hung CT; Shih SR
PLoS Pathog; 2009 Sep; 5(9):e1000593. PubMed ID: 19779565
[TBL] [Abstract][Full Text] [Related]
49. Cytoplasmic translocation, aggregation, and cleavage of TDP-43 by enteroviral proteases modulate viral pathogenesis.
Fung G; Shi J; Deng H; Hou J; Wang C; Hong A; Zhang J; Jia W; Luo H
Cell Death Differ; 2015 Dec; 22(12):2087-97. PubMed ID: 25976304
[TBL] [Abstract][Full Text] [Related]
50. The predominant elF4G-specific cleavage activity in poliovirus-infected HeLa cells is distinct from 2A protease.
Bovee ML; Marissen WE; Zamora M; Lloyd RE
Virology; 1998 Jun; 245(2):229-40. PubMed ID: 9636362
[TBL] [Abstract][Full Text] [Related]
51. Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy.
Badorff C; Lee GH; Lamphear BJ; Martone ME; Campbell KP; Rhoads RE; Knowlton KU
Nat Med; 1999 Mar; 5(3):320-6. PubMed ID: 10086389
[TBL] [Abstract][Full Text] [Related]
52. Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis.
Li M; Yan K; Wei L; Yang J; Lu C; Xiong F; Zheng C; Xu W
Antiviral Res; 2015 Nov; 123():50-61. PubMed ID: 26343012
[TBL] [Abstract][Full Text] [Related]
53. The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling.
Mukherjee A; Morosky SA; Delorme-Axford E; Dybdahl-Sissoko N; Oberste MS; Wang T; Coyne CB
PLoS Pathog; 2011 Mar; 7(3):e1001311. PubMed ID: 21436888
[TBL] [Abstract][Full Text] [Related]
54. Enterovirus 3C Protease Cleaves TRIM7 To Dampen Its Antiviral Activity.
Fan W; McDougal MB; Schoggins JW
J Virol; 2022 Oct; 96(19):e0133222. PubMed ID: 36106874
[TBL] [Abstract][Full Text] [Related]
55. Nitric oxide inhibits dystrophin proteolysis by coxsackieviral protease 2A through S-nitrosylation: A protective mechanism against enteroviral cardiomyopathy.
Badorff C; Fichtlscherer B; Rhoads RE; Zeiher AM; Muelsch A; Dimmeler S; Knowlton KU
Circulation; 2000 Oct; 102(18):2276-81. PubMed ID: 11056105
[TBL] [Abstract][Full Text] [Related]
56. Selective Removal of FG Repeat Domains from the Nuclear Pore Complex by Enterovirus 2A(pro).
Park N; Schweers NJ; Gustin KE
J Virol; 2015 Nov; 89(21):11069-79. PubMed ID: 26311873
[TBL] [Abstract][Full Text] [Related]
57. Picornavirus 2A protease regulates stress granule formation to facilitate viral translation.
Yang X; Hu Z; Fan S; Zhang Q; Zhong Y; Guo D; Qin Y; Chen M
PLoS Pathog; 2018 Feb; 14(2):e1006901. PubMed ID: 29415027
[TBL] [Abstract][Full Text] [Related]
58. Ubiquitin-like protein ISG15 (interferon-stimulated gene of 15 kDa) in host defense against heart failure in a mouse model of virus-induced cardiomyopathy.
Rahnefeld A; Klingel K; Schuermann A; Diny NL; Althof N; Lindner A; Bleienheuft P; Savvatis K; Respondek D; Opitz E; Ketscher L; Sauter M; Seifert U; Tschöpe C; Poller W; Knobeloch KP; Voigt A
Circulation; 2014 Oct; 130(18):1589-600. PubMed ID: 25165091
[TBL] [Abstract][Full Text] [Related]
59. New small-molecule inhibitors effectively blocking picornavirus replication.
Ford Siltz LA; Viktorova EG; Zhang B; Kouiavskaia D; Dragunsky E; Chumakov K; Isaacs L; Belov GA
J Virol; 2014 Oct; 88(19):11091-107. PubMed ID: 25008939
[TBL] [Abstract][Full Text] [Related]
60. Rhinovirus 3C protease facilitates specific nucleoporin cleavage and mislocalisation of nuclear proteins in infected host cells.
Walker EJ; Younessi P; Fulcher AJ; McCuaig R; Thomas BJ; Bardin PG; Jans DA; Ghildyal R
PLoS One; 2013; 8(8):e71316. PubMed ID: 23951130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
